Hormonal Contraceptives Market (By Product Type: Oral Contraceptive Pills, Vaginal Rings, Emergency Contraceptive Pills, Transdermal Patches, Injectable Birth Control; By Hormone: Combined Hormonal Contraceptive, Progestin-only Contraceptive; By End User: Hospitals, Clinics, Household) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

CHAPTER 1. INDUSTRY OVERVIEW

1.1. Definition and Scope
1.1.1. Definition of Hormonal Contraceptives
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Hormonal Contraceptives Market By Product Type
1.2.2.1. Global Hormonal Contraceptives Market Revenue and Growth Rate Comparison By Product Type (2015-2026)
1.2.2.2. Global Hormonal Contraceptives Market Revenue Share By Product Type in 2017
1.2.2.3. Oral Contraceptive Pills
1.2.2.4. Vaginal Rings
1.2.2.5. Emergency Contraceptive Pills
1.2.2.6. Transdermal Patches
1.2.2.7. Injectable Birth Control
1.2.3. Hormonal Contraceptives Market By Hormone
1.2.3.1. Global Hormonal Contraceptives Market Revenue and Growth Rate Comparison By Hormone (2015-2026)
1.2.3.2. Combined Hormonal Contraceptive
1.2.3.3. Progestin-only Contraceptive
1.2.4. Hormonal Contraceptives Market By End User
1.2.4.1. Global Hormonal Contraceptives Market Revenue and Growth Rate Comparison By End User (2015-2026)
1.2.4.2. Hospitals
1.2.4.3. Clinics
1.2.4.4. Household
1.2.5. Hormonal Contraceptives Market by Geography
1.2.5.1. Global Hormonal Contraceptives Market Revenue and Growth Rate Comparison by Geography (2015-2026)
1.2.5.2. North America Hormonal Contraceptives Market Revenue and Growth Rate (2015-2026)
1.2.5.3. Europe Hormonal Contraceptives Market Revenue and Growth Rate (2015-2026)
1.2.5.4. Asia-Pacific Hormonal Contraceptives Market Revenue and Growth Rate (2015-2026)
1.2.5.5. Latin America Hormonal Contraceptives Market Revenue and Growth Rate (2015-2026)
1.2.5.6. Middle East and Africa (MEA) Hormonal Contraceptives Market Revenue and Growth Rate (2015-2026)

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS

2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2017
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS

3.1. Capacity and Commercial Production Date of Global Hormonal Contraceptives Major Manufacturers in 2017
3.2. Manufacturing Plants Distribution of Global Hormonal Contraceptives Major Manufacturers in 2017
3.3. R&D Status and Technology Product Type of Global Hormonal Contraceptives Major Manufacturers in 2017
3.4. Raw Materials Sources Analysis of Global Hormonal Contraceptives Major Manufacturers in 2017

CHAPTER 4. HORMONAL CONTRACEPTIVES MARKET BY PRODUCT TYPE

4.1. Global Hormonal Contraceptives Revenue By Product Type
4.2. Oral Contraceptive Pills
4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.3. Vaginal Rings
4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.4. Emergency Contraceptive Pills
4.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.5. Transdermal Patches
4.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.6. Injectable Birth Control
4.6.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.6.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 5. HORMONAL CONTRACEPTIVES MARKET BY HORMONE

5.1. Global Hormonal Contraceptives Revenue By Hormone
5.2. Combined Hormonal Contraceptive
5.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.3. Progestin-only Contraceptive
5.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 6. HORMONAL CONTRACEPTIVES MARKET BY END USER

6.1. Global Hormonal Contraceptives Revenue By End User
6.2. Hospitals
6.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.3. Clinics
6.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.4. Household
6.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 7. NORTH AMERICA HORMONAL CONTRACEPTIVES MARKET BY COUNTRY

7.1. North America Hormonal Contraceptives Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.2. North America Hormonal Contraceptives Market Revenue Share Comparison, 2015 & 2026 (%)
7.3. U.S.
7.3.1. U.S. Hormonal Contraceptives Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
7.3.2. Market Revenue and Forecast By Hormone, 2015 - 2026 ($Million)
7.3.3. Market Revenue and Forecast By End User, 2015 - 2026 ($Million)
7.4. Canada
7.4.1. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
7.4.2. Market Revenue and Forecast By Hormone, 2015 - 2026 ($Million)
7.4.3. Market Revenue and Forecast By End User, 2015 - 2026 ($Million)
7.5. Mexico
7.5.1. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
7.5.2. Market Revenue and Forecast By Hormone, 2015 - 2026 ($Million)
7.5.3. Market Revenue and Forecast By End User, 2015 - 2026 ($Million)

CHAPTER 8. EUROPE HORMONAL CONTRACEPTIVES MARKET BY COUNTRY

8.1. Europe Hormonal Contraceptives Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.2. Europe Hormonal Contraceptives Market Revenue Share Comparison, 2015 & 2026 (%)
8.3. UK
8.3.1. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
8.3.2. Market Revenue and Forecast By Hormone, 2015 - 2026 ($Million)
8.3.3. Market Revenue and Forecast By End User, 2015 - 2026 ($Million)
8.4. Germany
8.4.1. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
8.4.2. Market Revenue and Forecast By Hormone, 2015 - 2026 ($Million)
8.4.3. Market Revenue and Forecast By End User, 2015 - 2026 ($Million)
8.5. France
8.5.1. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
8.5.2. Market Revenue and Forecast By Hormone, 2015 - 2026 ($Million)
8.5.3. Market Revenue and Forecast By End User, 2015 - 2026 ($Million)
8.6. Spain
8.6.1. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
8.6.2. Market Revenue and Forecast By Hormone, 2015 - 2026 ($Million)
8.6.3. Market Revenue and Forecast By End User, 2015 - 2026 ($Million)
8.7. Rest of Europe
8.7.1. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
8.7.2. Market Revenue and Forecast By Hormone, 2015 - 2026 ($Million)
8.7.3. Market Revenue and Forecast By End User, 2015 - 2026 ($Million)

CHAPTER 9. ASIA-PACIFIC HORMONAL CONTRACEPTIVES MARKET BY COUNTRY

9.1. Asia-Pacific Hormonal Contraceptives Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. Asia-Pacific Hormonal Contraceptives Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. China
9.3.1. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
9.3.2. Market Revenue and Forecast By Hormone, 2015 - 2026 ($Million)
9.3.3. Market Revenue and Forecast By End User, 2015 - 2026 ($Million)
9.4. Japan
9.4.1. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
9.4.2. Market Revenue and Forecast By Hormone, 2015 - 2026 ($Million)
9.4.3. Market Revenue and Forecast By End User, 2015 - 2026 ($Million)
9.5. India
9.5.1. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
9.5.2. Market Revenue and Forecast By Hormone, 2015 - 2026 ($Million)
9.5.3. Market Revenue and Forecast By End User, 2015 - 2026 ($Million)
9.6. Australia
9.6.1. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
9.6.2. Market Revenue and Forecast By Hormone, 2015 - 2026 ($Million)
9.6.3. Market Revenue and Forecast By End User, 2015 - 2026 ($Million)
9.7. South Korea
9.7.1. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
9.7.2. Market Revenue and Forecast By Hormone, 2015 - 2026 ($Million)
9.7.3. Market Revenue and Forecast By End User, 2015 - 2026 ($Million)
9.8. Rest of Asia-Pacific
9.8.1. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
9.8.2. Market Revenue and Forecast By Hormone, 2015 - 2026 ($Million)
9.8.3. Market Revenue and Forecast By End User, 2015 - 2026 ($Million)

CHAPTER 10. LATIN AMERICA HORMONAL CONTRACEPTIVES MARKET BY COUNTRY

10.1. Latin America Hormonal Contraceptives Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Latin America Hormonal Contraceptives Market Revenue Share Comparison, 2015 & 2026 (%)
10.3. Brazil
10.3.1. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
10.3.2. Market Revenue and Forecast By Hormone, 2015 - 2026 ($Million)
10.3.3. Market Revenue and Forecast By End User, 2015 - 2026 ($Million)
10.4. Argentina
10.4.1. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
10.4.2. Market Revenue and Forecast By Hormone, 2015 - 2026 ($Million)
10.4.3. Market Revenue and Forecast By End User, 2015 - 2026 ($Million)
10.5. Rest of Latin America
10.5.1. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
10.5.2. Market Revenue and Forecast By Hormone, 2015 - 2026 ($Million)
10.5.3. Market Revenue and Forecast By End User, 2015 - 2026 ($Million)

CHAPTER 11. MIDDLE EAST HORMONAL CONTRACEPTIVES MARKET BY COUNTRY

11.1. Middle East Hormonal Contraceptives Market Revenue and Growth Rate, 2015 - 2026 ($Million)
11.2. Middle East Hormonal Contraceptives Market Revenue Share Comparison, 2015 & 2026 (%)
11.3. Saudi Arabia
11.3.1. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
11.3.2. Market Revenue and Forecast By Hormone, 2015 - 2026 ($Million)
11.3.3. Market Revenue and Forecast By End User, 2015 - 2026 ($Million)
11.4. UAE
11.4.1. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
11.4.2. Market Revenue and Forecast By Hormone, 2015 - 2026 ($Million)
11.4.3. Market Revenue and Forecast By End User, 2015 - 2026 ($Million)
11.5. Rest of Middle East
11.5.1. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
11.5.2. Market Revenue and Forecast By Hormone, 2015 - 2026 ($Million)
11.5.3. Market Revenue and Forecast By End User, 2015 - 2026 ($Million)

CHAPTER 12. AFRICA HORMONAL CONTRACEPTIVES MARKET BY COUNTRY

12.1. Africa Hormonal Contraceptives Market Revenue and Growth Rate, 2015 - 2026 ($Million)
12.2. Africa Hormonal Contraceptives Market Revenue Share Comparison, 2015 & 2026 (%)
12.3. South Africa
12.3.1. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
12.3.2. Market Revenue and Forecast By Hormone, 2015 - 2026 ($Million)
12.3.3. Market Revenue and Forecast By End User, 2015 - 2026 ($Million)
12.4. Egypt
12.4.1. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
12.4.2. Market Revenue and Forecast By Hormone, 2015 - 2026 ($Million)
12.4.3. Market Revenue and Forecast By End User, 2015 - 2026 ($Million)
12.5. Rest of Africa
12.5.1. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
12.5.2. Market Revenue and Forecast By Hormone, 2015 - 2026 ($Million)
12.5.3. Market Revenue and Forecast By End User, 2015 - 2026 ($Million)

CHAPTER 13. COMPANY PROFILE

13.1. Allergan
13.1.1. Company Snapshot
13.1.2. Overview
13.1.3. Financial Overview
13.1.4. Type Portfolio
13.1.5. Key Developments
13.1.6. Strategies
13.2. Pfizer
13.2.1. Company Snapshot
13.2.2. Overview
13.2.3. Financial Overview
13.2.4. Type Portfolio
13.2.5. Key Developments
13.2.6. Strategies
13.3. Afaxys, Inc.
13.3.1. Company Snapshot
13.3.2. Overview
13.3.3. Financial Overview
13.3.4. Type Portfolio
13.3.5. Key Developments
13.3.6. Strategies
13.4. Agile Therapeutics
13.4.1. Company Snapshot
13.4.2. Overview
13.4.3. Financial Overview
13.4.4. Type Portfolio
13.4.5. Key Developments
13.4.6. Strategies
13.5. Bayer AG
13.5.1. Company Snapshot
13.5.2. Overview
13.5.3. Financial Overview
13.5.4. Type Portfolio
13.5.5. Key Developments
13.5.6. Strategies
13.6. Merck & Co. Inc.
13.6.1. Company Snapshot
13.6.2. Overview
13.6.3. Financial Overview
13.6.4. Type Portfolio
13.6.5. Key Developments
13.6.6. Strategies
13.7. Teva Pharmaceuticals Industries Ltd.
13.7.1. Company Snapshot
13.7.2. Overview
13.7.3. Financial Overview
13.7.4. Type Portfolio
13.7.5. Key Developments
13.7.6. Strategies
13.8. Apothecus Pharmaceutical Corporation
13.8.1. Company Snapshot
13.8.2. Overview
13.8.3. Financial Overview
13.8.4. Type Portfolio
13.8.5. Key Developments
13.8.6. Strategies
13.9. Others
13.9.1. Company Snapshot
13.9.2. Overview
13.9.3. Financial Overview
13.9.4. Type Portfolio
13.9.5. Key Developments
13.9.6. Strategies

CHAPTER 14. RESEARCH APPROACH

14.1. Research Methodology
14.1.1. Initial Data Search
14.1.2. Secondary Research
14.1.3. Primary Research
14.2. Assumptions and Scope